Fibrinolysis.
D000614:Aminocaproates / Q000494:pharmacology; D045930:Anabolic Agents / Q000494:pharmacology; D000728:Androgens / Q000494:pharmacology; D000933:Antifibrinolytic Agents / Q000188:drug therapy; D001157:Arterial Occlusive Diseases / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects; D002994:Clofibrate / Q000494:pharmacology; D004338:Drug Combinations; D005032:Ethylestrenol / Q000494:pharmacology; D005337:Fibrin / Q000502:physiology; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000502:physiology; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000097:blood; D007328:Insulin / Q000494:pharmacology; D008722:Methods; D010629:Phenformin / Q000494:pharmacology; D010958:Plasminogen / Q000502:physiology; D013453:Sulfonylurea Compounds / Q000494:pharmacology
D000614:Aminocaproates; D045930:Anabolic Agents; D000728:Androgens; D000933:Antifibrinolytic Agents; D004338:Drug Combinations; D007328:Insulin; D013453:Sulfonylurea Compounds; D005337:Fibrin; D010958:Plasminogen; D005032:Ethylestrenol; D010629:Phenformin; D005341:Fibrinolysin; D002994:Clofibrate